Boston Partners

Q2 2021 13F-HR Detailed Holdings

Location
Boston, MA
Holdings as of
6/30/2021
Date filed
8/12/2021
Form type
13F-HR
Num holdings
1,702
Total value ($000)
$78,413,656
Net value change ($000)
+3,845,814 (5.2%)
New positions
40
Sold out positions
39
Turnover %
3.3%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
WFC 398,401 364.9%
CNC 384,908 129.4%
QCOM 384,470 NEW
PII 380,142 NEW
GEN 329,752 NEW
WAB 293,812 NEW
SONY 275,431 4472.0%
AVTR 229,446 43.7%
UNH 182,537 34.9%
META 178,137 56.1%
Top Reduces (Value $000, Stocks/ETFs)
MDT -361,554 -54.0%
STLD -284,097 -80.0%
MTZ -204,219 -100.0%
BAC -195,079 -16.9%
HBAN -183,048 -23.1%
TMUS -180,353 -32.0%
BBY -139,626 -63.1%
PCAR -131,274 -67.7%
RGA -127,587 -92.7%
AMGN -122,024 -41.9%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 ORIX Corp Europe N.V. 028-12637
2 Robeco Institutional Asset Management B.V. 028-12635
3 Boston Partners Trust Co 028-13904
4 ORIX CORP 028-18337